Shkreli’s bearish stance on Microstrategy: Martin Shkreli, known as Pharma Bro, publicly denounces Microstrategy’s Bitcoin strategy. He argues that taking on debt to invest in Bitcoin is a reckless move, reflecting poorly on Saylor’s leadership amid the company’s soaring stock value.
Microstrategy’s remarkable stock performance: Despite Shkreli’s skepticism, Microstrategy has seen its stock increase significantly, rising over 600% to above 400 USD per share. With a Bitcoin reserve of over 423,000 BTC worth more than 43 billion USD, the company’s valuation skyrocketed.
Leave a Reply